Jazz Pharmaceuticals
JAZZ
#1802
Rank
โ‚น1.032 T
Marketcap
โ‚น16,780
Share price
-0.51%
Change (1 day)
38.93%
Change (1 year)

Earnings for Jazz Pharmaceuticals (JAZZ)

Earnings in 2025 (TTM): -โ‚น60.21 Billion

According to Jazz Pharmaceuticals's latest financial reports the company's current earnings are โ‚น4.15 Billion. In 2024 the company made an earning of โ‚น43.73 Billion, an increase over its 2023 earnings that were of โ‚น27.70 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Jazz Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น60.21 Billion-237.64%
2024 โ‚น43.73 B57.87%
2023 โ‚น27.70 B-179.92%
2022 -โ‚น34.67 Billion230.37%
2021 -โ‚น10.5 Billion-141.02%
2020 โ‚น25.58 B-39.45%
2019 โ‚น42.24 B-14.2%
2018 โ‚น49.23 B20.03%
2017 โ‚น41.01 B-17.15%
2016 โ‚น49.51 B22.14%
2015 โ‚น40.53 B187.64%
2014 โ‚น14.09 B-50.79%
2013 โ‚น28.63 B73.63%
2012 โ‚น16.49 B41.69%
2011 โ‚น11.63 B116.61%
2010 โ‚น5.37 B262.77%
2009 โ‚น1.48 B-111.33%
2008 -โ‚น13.08 Billion1.31%
2007 -โ‚น12.91 Billion77.8%
2006 -โ‚น7.26 Billion36.59%
2005 -โ‚น5.32 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
โ‚น1.520 T-2,425.66%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AmerisourceBergen
ABC
โ‚น194.97 B-398.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Endo International
ENDPQ
-โ‚น222.43 Billion 240.19%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Teva Pharmaceutical Industries
TEVA
โ‚น200.11 B-406.07%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel